摘要
目的:建立测定人血浆中阿折地平浓度的方法。方法:人血浆样本经乙腈沉淀蛋白后采用液相色谱-串联质谱(LC-MS/MS)法进样测定,色谱柱为Zorbax Eclipse XDB-C18,流动相为甲醇-10 mmol/L乙酸铵(含1%甲酸)(80∶20,V/V)。选用多重反应监测扫描方式进行质谱监测,监测离子反应分别为m/z 583.3→167.1(阿折地平)、m/z 285.1→154.0(内标地西泮)。结果:阿折地平的血药浓度在0.05~40 ng/ml范围内线性关系良好,定量下限为0.05 ng/ml。日内、日间RSD分别为3.01%~7.75%,0.99%~12.08%;平均提取回收率为110.20%~111.99%。结论:该方法简便、快速、灵敏、专属性强、重现性好,适用于人血浆中阿折地平浓度的测定。
OBJECTIVE:To establish a method for the content determination of azelnidipine. METHODS:Plasma samples were processed by protein precipitation and determined by LC-MS/MS. Chromatography was performed on a Zorbax Eclipse XDB-C18 column using mobile phases of methanol-10 mmol/L ammonium acetate(containing 1% formic acid)(80∶20,V/V). The MS detection was used multiple reaction monitoring mode with MS/MS ion transitions at m/z 583.3→167.1(azelnidipine)and m/z285.1→154.0(internal standard diazepam). RESULTS:There was a good relationship of blood concentration in the range of0.05-40 ng/ml in plasma with the lower limit of quantitation of 0.05 ng/ml. The RSD of intra- and inter-day was 3.01%-7.75%,0.99%-12.08%,respectively. The extraction recovery was 110.20%-111.99%. CONCLUSIONS:This is a rapid,sensitive,selective and reliable method for the determination of azelnidipine in human plasma.
出处
《中国药房》
CAS
北大核心
2015年第8期1073-1075,共3页
China Pharmacy